🇺🇸 FDA
Pipeline program

cyclophosphamide

199/14975

Phase 1 small_molecule completed

Quick answer

cyclophosphamide for Multiple Sclerosis is a Phase 1 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Multiple Sclerosis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials